At 98, Walter Bingham is a marvel. From Holocaust survivor to World War II hero, to serving as a journalist for 50 years, Bingham has experienced a lot. When he was 93, Guinness World Records deemed Walter “the oldest radio talk show host living.” Two years ago, Israel’s Government Press Office honored him as the “oldest active correspondent in the world.” And a year later at 97, Guinness certified him as the “oldest journalist,” and he’s still going strong.
At 98, Walter Bingham is a marvel. From Holocaust survivor to World War II hero, to serving as a journalist for 50 years, Bingham has experienced a lot. When he was 93, Guinness World Records deemed Walter “the oldest radio talk show host living.” Two years ago, Israel’s Government Press Office honored him as the “oldest active correspondent in the world.” And a year later at 97, Guinness certified him as the “oldest journalist,” and he’s still going strong.
Now into our third year of the COVID-19 pandemic, the Omicron wave seems to be receding in many parts of the country, but the virus is showing no signs of leaving us. The question now seems to be, when will this virus transition from being a pandemic in which everyone continues to take maximum precautions in order to prevent getting infected, and into an endemic mode, one in which we learn to live with it? A Monmouth University poll out this week finds 7 in 10 Americans agree that it’s time to accept COVID-19 is here to stay and we need to get on with our lives. Is that true and, if so, how do we do that? CBN News Medical Reporter Lorie Johnson joins the show to discuss. Also, is Israel capable of launching a successful military strike against Iran to stop their nuclear weapons program? In 2015, when the Obama administration and other western nations reached a deal with Iran on their nuclear program, the US estimated Iran’s breakout time would be 12 months. Now, officials believe t
It’s the first of its kind – an oral drug that could help treat symptoms from COVID-19. Health experts have been calling for a convenient pill that COVID-19 patients could take at the onset of symptoms. The pharmaceutical company “Merck” answered that call and developed a new oral drug called “Molnupiravir.” The U.S government has already approved one antiviral drug called remdesivir to treat COVID-19, but it is primarily taken intravenously. If authorized by the FDA, Molnupiravir would become the first oral medicine to fight Covid-19, and you might be able to pick it up at your local pharmacy with a prescription by the end of the year. CBN News Middle East Bureau Chief Chris Mitchell talked to an Israeli disease expert and professor about the drug’s progress, and he's on today's podcast to discuss.
Could Israel and Iran Ever Become Friends? Some Say Yes cbn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbn.com Daily Mail and Mail on Sunday newspapers.